These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16417428)

  • 21. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice.
    Hezarjaribi HZ; Ghaffarifar F; Dalimi A; Sharifi Z; Jorjani O
    Exp Parasitol; 2013 Jul; 134(3):341-8. PubMed ID: 23541883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania major parasite stage-dependent host cell invasion and immune evasion.
    Wenzel UA; Bank E; Florian C; Förster S; Zimara N; Steinacker J; Klinger M; Reiling N; Ritter U; van Zandbergen G
    FASEB J; 2012 Jan; 26(1):29-39. PubMed ID: 21908716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells.
    Belkaid Y; Butcher B; Sacks DL
    Eur J Immunol; 1998 Apr; 28(4):1389-400. PubMed ID: 9565379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
    Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
    J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania major-parasitized macrophages augment Th2-type T cell activation.
    Chakkalath HR; Titus RG
    J Immunol; 1994 Nov; 153(10):4378-87. PubMed ID: 7963516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.
    Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A
    Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypically distinct strains of Leishmania major display diverse clinical and immunological patterns in BALB/c mice.
    Alimohammadian MH; Darabi H; Ajdary S; Khaze V; Torkabadi E
    Infect Genet Evol; 2010 Oct; 10(7):969-75. PubMed ID: 20601170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response.
    Hondowicz BD; Scharton-Kersten TM; Jones DE; Scott P
    J Immunol; 1997 Nov; 159(10):5024-31. PubMed ID: 9366430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
    Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library.
    Rhaiem RB; Houimel M
    Acta Trop; 2016 Jul; 159():11-9. PubMed ID: 26995695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection with Leishmania major induces interleukin-12 production in vivo.
    Vieira LQ; Hondowicz BD; Afonso LC; Wysocka M; Trinchieri G; Scott P
    Immunol Lett; 1994 May; 40(2):157-61. PubMed ID: 7916331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.
    Dumas C; Muyombwe A; Roy G; Matte C; Ouellette M; Olivier M; Papadopoulou B
    Infect Immun; 2003 Nov; 71(11):6499-509. PubMed ID: 14573672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.